• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化中的导管细胞。

The duct cell in cystic fibrosis.

作者信息

Harris A

机构信息

Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, UK.

出版信息

Ann N Y Acad Sci. 1999 Jun 30;880:17-30. doi: 10.1111/j.1749-6632.1999.tb09506.x.

DOI:10.1111/j.1749-6632.1999.tb09506.x
PMID:10415847
Abstract

The pancreatic duct cell is central to the etiology of cystic fibrosis (CF) and is the site where pathology commences in utero. We have evaluated expression of the cystic fibrosis transmembrane conductance regulator gene (CFTR) through human development and shown it to be expressed from the early mid-trimester, with highest levels in the most distal portion of the developing duct system and in centroacinar cells. The precise cause of pancreatic destruction in CF is thought to be the obstruction of pancreatic ducts with inspissated secretions. We have shown that the MUC6 mucin is a significant component of the material that obstructs the ducts and that the MUC6 gene shows a very similar pattern of expression to that of CFTR in the developing pancreas. These observations provide a starting point for investigating how mutations in CFTR lead to obstruction of the pancreatic ducts in CF.

摘要

胰腺导管细胞在囊性纤维化(CF)的病因学中起核心作用,是子宫内病理过程开始的部位。我们评估了囊性纤维化跨膜传导调节因子基因(CFTR)在人类发育过程中的表达情况,结果显示该基因从中孕期早期开始表达,在发育中的导管系统最远端部分以及腺泡中心细胞中表达水平最高。CF中胰腺破坏的确切原因被认为是浓稠分泌物阻塞胰腺导管。我们已经表明,MUC6粘蛋白是阻塞导管物质的重要组成部分,并且MUC6基因在发育中的胰腺中的表达模式与CFTR非常相似。这些观察结果为研究CFTR突变如何导致CF患者的胰腺导管阻塞提供了一个起点。

相似文献

1
The duct cell in cystic fibrosis.囊性纤维化中的导管细胞。
Ann N Y Acad Sci. 1999 Jun 30;880:17-30. doi: 10.1111/j.1749-6632.1999.tb09506.x.
2
Cystic fibrosis of the pancreas: involvement of MUC6 mucin in obstruction of pancreatic ducts.
Mol Med. 1997 Jun;3(6):403-11.
3
The cystic fibrosis transmembrane conductance regulator as a marker of human pancreatic duct development.囊性纤维化跨膜传导调节因子作为人类胰管发育的标志物。
Gastroenterology. 1997 Sep;113(3):914-9. doi: 10.1016/s0016-5085(97)70187-2.
4
Expression of the cystic fibrosis gene and the major pancreatic mucin gene, MUC1, in human ductal epithelial cells.
J Cell Sci. 1993 Jun;105 ( Pt 2):417-22. doi: 10.1242/jcs.105.2.417.
5
Loss of cftr function leads to pancreatic destruction in larval zebrafish.囊性纤维化跨膜传导调节因子(CFTR)功能丧失会导致斑马鱼幼体的胰腺破坏。
Dev Biol. 2015 Mar 15;399(2):237-48. doi: 10.1016/j.ydbio.2014.12.034. Epub 2015 Jan 13.
6
Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells.使用多能干细胞衍生的人胰腺导管上皮细胞建立囊性纤维化模型。
Stem Cells Transl Med. 2016 May;5(5):572-9. doi: 10.5966/sctm.2015-0276. Epub 2016 Mar 31.
7
Cystic fibrosis transmembrane conductance regulator is expressed in mucin granules from Calu-3 and primary human airway epithelial cells.囊性纤维化跨膜电导调节蛋白存在于 Calu-3 细胞和原代人呼吸道上皮细胞的粘蛋白颗粒中。
Am J Respir Cell Mol Biol. 2013 Oct;49(4):511-6. doi: 10.1165/rcmb.2012-0419RC.
8
The characterization of the first anti-mouse Muc6 antibody shows an increased expression of the mucin in pancreatic tissue of Cftr-knockout mice.对首个抗鼠 Muc6 抗体的特性分析表明,在 Cftr 基因敲除小鼠的胰腺组织中黏蛋白表达增加。
Histochem Cell Biol. 2010 May;133(5):517-25. doi: 10.1007/s00418-010-0688-8. Epub 2010 Mar 23.
9
CFTR, mucins, and mucus obstruction in cystic fibrosis.囊性纤维化中的 CFTR、黏蛋白和黏液阻塞。
Cold Spring Harb Perspect Med. 2012 Sep 1;2(9):a009589. doi: 10.1101/cshperspect.a009589.
10
CFTR gene transfer to human cystic fibrosis pancreatic duct cells using a Sendai virus vector.使用仙台病毒载体将CFTR基因转移至人囊性纤维化胰腺导管细胞。
J Cell Physiol. 2008 Feb;214(2):442-55. doi: 10.1002/jcp.21220.

引用本文的文献

1
Increased expression of anion transporter SLC26A9 delays diabetes onset in cystic fibrosis.阴离子转运蛋白 SLC26A9 的过度表达延缓了囊性纤维化中的糖尿病发病。
J Clin Invest. 2020 Jan 2;130(1):272-286. doi: 10.1172/JCI129833.